Health

Statin drugs going generic

NEWS IN BRIEF — Posted May 15, 2006

Print  |   Email  |   Respond  |   Reprints  |   Like Facebook  |   Share Twitter  |   Tweet Linkedin

A generic version of Pravachol, or pravastatin sodium, one of the top-selling cholesterol-lowering drugs, was approved by the Food and Drug Administration April 24. Pravachol lost patent protection April 20. Similar action is expected next month for another top seller, Zocor, or simvastatin, when that drug goes off-patent.

Pravastatin, manufactured in 10 mg, 20 mg and 40 mg, is one of several popular cholesterol-lowering medications. In 2005, Pravachol was the 22nd highest-selling brand-name drug in the United States, with sales totaling $1.3 billion. Insurers already are asking physicians to begin to switch patients from brand name to lower-price generic statins.

said Christie Ballantyne, MD, director of Baylor Medical College's Center for Cardiovascular Disease Prevention -- a not unusual occurrence with a change to any generic medication.

Physicians whose patients have been prescribed brand-name statins for many years are likely to find varying efficacy rates among the brands making it necessary to recheck liver functions and step up monitoring for muscle pain, at least initially, he noted.

It is likely that generic statins will save patients as well as the health care system a great deal of money, Dr. Ballantyne noted. An analysis by Consumers Union indicated that if Medicare Part D beneficiaries alone were prescribed effective generic statins instead of brand-name medications, the savings could mount to $8.2 billion next year.

Pricing information for the new generic pravastatin was expected shortly.

Note: This item originally appeared at http://www.ama-assn.org/amednews/2006/05/15/hlbf0515.htm.

Back to top


ADVERTISEMENT

ADVERTISE HERE


Featured
Read story

Confronting bias against obese patients

■ Medical educators are starting to raise awareness about how weight-related stigma can impair patient-physician communication and the treatment of obesity. Read story


Read story

Goodbye

■ American Medical News is ceasing publication after 55 years of serving physicians by keeping them informed of their rapidly changing profession. Read story


Read story

Policing medical practice employees after work

■ Doctors can try to regulate staff actions outside the office, but they must watch what they try to stamp out and how they do it. Read story


Read story

Diabetes prevention: Set on a course for lifestyle change

■ The YMCA's evidence-based program is helping prediabetic patients eat right, get active and lose weight. Read story


Read story

Medicaid's muddled preventive care picture

■ The health system reform law promises no-cost coverage of a lengthy list of screenings and other prevention services, but some beneficiaries still might miss out. Read story


Read story

How to get tax breaks for your medical practice

■ Federal, state and local governments offer doctors incentives because practices are recognized as economic engines. But physicians must know how and where to find them. Read story


Read story

Advance pay ACOs: A down payment on Medicare's future

■ Accountable care organizations that pay doctors up-front bring practice improvements, but it's unclear yet if program actuaries will see a return on investment. Read story


Read story

Physician liability: Your team, your legal risk

■ When health care team members drop the ball, it's often doctors who end up in court. How can physicians improve such care and avoid risks? Read story

  • Stay informed
  • Twitter
  • Facebook
  • RSS
  • LinkedIn